Global medical power research has achieved a major breakthrough in 2026: a fully biodegradable and biologically compatible medical battery has been successfully developed, solving the core defect of traditional implantable medical batteries that require secondary surgical removal. This original green medical compatible power technology provides a safe and efficient new power solution for temporary implantable medical devices, opening a new era of environmentally friendly and minimally invasive medical power supply.
Different from traditional lithium-based implantable batteries, this innovative medical compatible battery is made of natural biodegradable polymer materials and non-toxic neutral electrolyte components, with excellent human tissue compatibility. It produces no immune rejection, inflammatory reactions, or toxic side effects during in-vivo operation. After completing the preset short-term power supply tasks for postoperative monitoring sensors, minimally invasive treatment auxiliary devices, and temporary physiological signal collectors, the battery can be automatically degraded and absorbed by human tissues without surgical removal, greatly reducing patients’ treatment pain and postoperative recovery risks.
In terms of operational compatibility and performance stability, the biodegradable battery supports precise adjustable low-power long-duration output, which perfectly matches the power demand of miniature implantable medical monitoring equipment. It maintains stable and consistent discharge performance in constant-temperature human tissue fluid environments, with accurate and controllable power supply duration. Researchers have optimized the internal microscopic structure of the battery, overcoming the technical bottlenecks of low energy density and unstable output of early biodegradable power products, making its comprehensive performance fully compliant with clinical medical application standards.
At present, this biodegradable medical compatible battery has completed multiple rounds of biological safety tests and laboratory clinical verification, and is scheduled to enter formal clinical trial stages by the end of 2026. The technology is particularly suitable for pediatric minimally invasive treatment, short-term postoperative physiological monitoring, and temporary implantable diagnosis scenarios. With further technological maturity and performance optimization, it is expected to replace a large number of traditional non-degradable implantable batteries and become a core development direction of future high-end medical compatible power supplies.